Show simple item record

dc.contributor.authorConole, Den_US
dc.contributor.authorMyers, SHen_US
dc.contributor.authorMota, Fen_US
dc.contributor.authorHobbs, AJen_US
dc.contributor.authorSelwood, DLen_US
dc.date.accessioned2018-10-04T10:31:45Z
dc.date.available2018-09-04en_US
dc.date.issued2019-06en_US
dc.date.submitted2018-09-28T08:58:36.163Z
dc.identifier.other10.1111/cbdd.13395
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13395
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/45923
dc.descriptionThis is the peer reviewed version of the following article:Conole, D., et al. "Biophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands." Chemical Biology and Drug Design 0(ja)., which has been published in final form at [https://doi.org/10.1111/cbdd.13395. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versionsen_US
dc.description.abstractEndothelium-derived C-type natriuretic peptide possesses cytoprotective and anti-atherogenic functions that regulate vascular homeostasis. The vasoprotective effects of C-type natriuretic peptide are somewhat mediated by the natriuretic peptide receptor C, suggesting that this receptor represents a novel therapeutic target for the treatment of cardiovascular diseases. In order to facilitate our drug discovery efforts, we have optimized an array of biophysical methods including surface plasmon resonance, fluorescence polarization and thermal shift assays to aid in the design, assessment and characterization of small molecule agonist interactions with natriuretic peptide receptors. Assay conditions are investigated to explore the feasibility and dynamic range of each method, and peptide-based agonists and antagonists are used as controls to validate these conditions. Once established, each technique was compared and contrasted with respect to their drug discovery utility. We foresee that such techniques will facilitate the discovery and development of potential therapeutic agents for NPR-C and other large extracellular domain membrane receptors.en_US
dc.description.sponsorshipThis work was funded by a translational award from the British Heart Foundation(TG/15/3/31692), Wellcome Trust grants (084449/Z/07/Z and 078496/Z/05/Z), UCL Business PLC (PoC-12-007)and an Apollo Therapeutics one-off experiment funden_US
dc.format.extent1011 - 1020en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofChem Biol Drug Desen_US
dc.rightsAll rights reserved
dc.subjectCNPen_US
dc.subjectNPR-Cen_US
dc.subjectbiophysicalen_US
dc.subjectfluorescence polarizationen_US
dc.subjectsurface plasmon resonanceen_US
dc.subjectthermal shiften_US
dc.titleBiophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands.en_US
dc.typeArticle
dc.rights.holderJohn Wiley & Sons, Inc.
dc.identifier.doi10.1111/cbdd.13395en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30218492en_US
pubs.issue6en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume93en_US
dcterms.dateAccepted2018-09-04en_US
qmul.funderLead optimisation of novel small molecule natriuretic receptor (NPR)-C agonists for the treatment of myocardial infarction::British Heart Foundationen_US
qmul.funderLead optimisation of novel small molecule natriuretic receptor (NPR)-C agonists for the treatment of myocardial infarction::British Heart Foundationen_US
qmul.funderLead optimisation of novel small molecule natriuretic receptor (NPR)-C agonists for the treatment of myocardial infarction::British Heart Foundationen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record